27/03/2017 05:56 AST

The board of directors of Julphar Gulf Pharmaceutical Industries has decided to appoint chief financial officer Jerome Carle as acting general manager.

The appointment will be effective following the departure of current chief executive officer Dr Ayman Sahli on April 20 and until a new CEO is appointed, said a statement.

His Highness Sheikh Faisal Bin Saqr Al Qassimi, Chairman of Julphar, said: “The board believes that Jerome is the right person to drive Julphar while we are looking for a new and highly qualified candidate to fill the CEO role, and we are grateful for Jerome’s readiness to endorse the role at this time. I want to thank Dr Ayman Sahli for his outstanding service to the company the past eight years, and I personally wish him well in the future."

Carle commented: “I would like to thank the Board of Directors for their trust. I am looking forward to working under their guidance. Together with the executive team, I am confident that we will prepare a smooth transition until our new CEO is appointed and ensure that Julphar is in the right direction to reach our 2020 vision.”

Established in 1980, Julphar is the largest generic pharmaceutical manufacturer in Middle East and North Africa, producing over 200 branded products across its 15 manufacturing facilities.


Trade Arabia

Julphar named top pharma company in UAE

04/04/2018

Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit s

Trade Arabia

Julphar records Dh1.3b in turnover for 2017

07/03/2018

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales of Dh1.3 billion for the year ending December 31, 2017, despite a challenging and rapidly changi

Gulf News

Julphar posts Dh86m in third-quarter profit

20/11/2017

Julphar Gulf Pharmaceutical Industries on Sunday said its net profit for the third quarter of this year reached Dh86 million, and that revenues for the first three quarters of this year amounted to D

Gulfnews

Ticker Price Volume
SABIC 114.77 5,915,941
SAMBA 26.98 1,138,683
DARALARKAN 13.47 74,648,349
JULPHAR Sector Market
P/E
Price/BookValue
Dividend Yield (%)
Relative Strength
  • 1-Month
  • 3-Month
  • 1-Year
Volume Change
  • 10D Avg Vs 90D Avg
Price Vs…
  • 52-w high
  • 50-day moving avg.
  • 200-Day Moving Avg
Ticker Price Change
IQCD 108.99 0.99 (0.91%)
QEWS 186.60 -1.50 (-0.80%)
MPHC 15.10 -0.17 (-1.12%)
AGLTY 825.00 -10.00 (-1.20%)
ALBH 0.56 0.00 (0.00%)
SABIC-MCC joint venture starts output

05/04/2018

SABIC announced the successful completion of the pilot operation of the Methyl Methacrylate Monomer (MMA) and Poly Methyl Methacrylate (PMMA) plants and the commencement of commercial operations.

Saudi Gazette

S&P affirms QIB rating at A-

05/04/2018

Standard & Poor’s (S&P) has affirmed QIB’s Issuer Credit Rating at A-, Qatar’s leading Islamic bank has said in a release. According to S&P, the major contributing factors strengthening QIB’s rating

Gulf Times

Qatar National Bank seeks growth in Southeast Asia

05/04/2018

Qatar National Bank (QNB) aims to increase its profit by 5-8 percent this year and loans and investments by 10-12 percent, helped by expansion into faster-growing Southeast Asia markets, its CEO told

The Peninsula

Doha Bank’s third Indian branch opens today

04/04/2018

Doha Bank has announced the official inauguration of its Chennai Branch, in the southern Indian state, will be held today. This is Doha Bank’s third city in India after its successful establishment o

The Peninsula

SHUAA to act as liquidity provider to Bank of Sharjah

04/04/2018

Bank of Sharjah said it has engaged SHUAA Capital International as liquidity providers for its shares and will commence the activity from April 4. SHUAA Capital International shall not hold more than

Gulf News